OTC Markets OTCQB - Delayed Quote USD

Lobe Sciences Ltd. (LOBEF)

Compare
0.0014 0.0000 (0.00%)
At close: October 15 at 4:00 PM EDT
Loading Chart for LOBEF
DELL
  • Previous Close 0.0121
  • Open 0.0121
  • Bid 0.0125 x --
  • Ask 0.0180 x --
  • Day's Range 0.0120 - 0.0121
  • 52 Week Range 0.0010 - 0.0180
  • Volume 49,000
  • Avg. Volume 36,923
  • Market Cap (intraday) 258,168
  • Beta (5Y Monthly) 2.28
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date Jul 26, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Lobe Sciences Ltd., a biopharmaceutical company, focuses on the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.

www.lobesciences.com

--

Full Time Employees

August 31

Fiscal Year Ends

Recent News: LOBEF

View More

Performance Overview: LOBEF

Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

LOBEF
16.67%
S&P/TSX Composite index
17.19%

1-Year Return

LOBEF
6.67%
S&P/TSX Composite index
26.19%

3-Year Return

LOBEF
92.13%
S&P/TSX Composite index
24.20%

5-Year Return

LOBEF
92.13%
S&P/TSX Composite index
24.20%

Compare To: LOBEF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LOBEF

View More

Valuation Measures

Annual
As of 10/16/2024
  • Market Cap

    2.49M

  • Enterprise Value

    4.07M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.27

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    5.75

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -62.09%

  • Return on Equity (ttm)

    -4,833.77%

  • Revenue (ttm)

    976.74k

  • Net Income Avi to Common (ttm)

    -2.97M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    40.99k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.7M

Company Insights: LOBEF

People Also Watch